Published in J Cell Biol on November 01, 1989
Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest (1995) 1.36
Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest (1991) 1.04
Nuclear factor Y is required for basal activation and chromatin accessibility of fibroblast growth factor receptor 2 promoter in osteoblast-like cells. J Biol Chem (2008) 0.95
In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol (2001) 0.95
Alendronate inhibits PTH (1-34)-induced bone morphogenetic protein expression in MC3T3-E1 preosteoblastic cells. HSS J (2007) 0.85
Autologous bone grafts with MSCs or FGF-2 accelerate bone union in large bone defects. J Orthop Surg Res (2016) 0.75
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem (1984) 66.58
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell (1987) 20.61
Transcriptional regulation of hemoglobin switching in chicken embryos. Mol Cell Biol (1981) 9.97
Transcriptional regulation of the ovalbumin and conalbumin genes by steroid hormones in chick oviduct. J Biol Chem (1979) 9.48
Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A (1985) 5.93
In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol (1983) 5.39
Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25
Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08
Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem (1988) 3.98
Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem (1988) 3.91
A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell (1988) 3.72
Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J Cell Physiol (1989) 3.58
Structural characterization and biological functions of fibroblast growth factor. Endocr Rev (1987) 3.40
Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature (1987) 3.31
Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell (1987) 3.17
Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem (1988) 3.13
The TGF-beta family of growth and differentiation factors. Cell (1987) 2.86
Mesoderm induction in amphibians: the role of TGF-beta 2-like factors. Science (1988) 2.68
A maternal mRNA localized to the vegetal hemisphere in Xenopus eggs codes for a growth factor related to TGF-beta. Cell (1987) 2.64
Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem (1986) 2.61
Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem (1986) 2.50
Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem (1989) 2.40
Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol (1988) 2.37
Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0----G1 transition. Proc Natl Acad Sci U S A (1987) 2.27
Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci U S A (1985) 2.17
Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem (1987) 2.17
The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol (1987) 2.04
Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol (1987) 2.01
Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis. Nature (1988) 1.99
Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J Biol Chem (1989) 1.97
Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun (1986) 1.90
Growth factors and the regulation of bone remodeling. J Clin Invest (1988) 1.73
In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology (1989) 1.63
Fibroblast growth factors. FASEB J (1987) 1.55
Cloning and sequence analysis of simian transforming growth factor-beta cDNA. DNA (1987) 1.54
Fibroblast growth factor: structural and biological properties. J Cell Physiol Suppl (1987) 1.52
Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts. J Biol Chem (1986) 1.43
Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. Endocrinology (1987) 1.42
Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest (1988) 1.32
Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor. J Biol Chem (1988) 1.32
Effect of growth factors on bone cell replication and differentiation. Clin Orthop Relat Res (1985) 1.18
Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology (1988) 1.14
Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology (1989) 1.13
Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. Endocrinology (1986) 1.09
Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun (1986) 1.07
Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol (1989) 1.03
Mitogenesis in fetal rat bone cells simultaneously exposed to type beta transforming growth factor and other growth regulators. FASEB J (1987) 0.95
Transforming potential of fibroblast growth factor genes. Trends Biochem Sci (1988) 0.94
Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. Endocrinology (1987) 0.94
Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells. Endocrinology (1989) 0.93
Cyclic AMP-mediated stabilization of osteocalcin mRNA in rat osteoblast-like cells treated with parathyroid hormone. J Biol Chem (1988) 0.91
Effects of endothelial cell growth factor on bone remodelling in vitro. J Clin Invest (1987) 0.89
Effect of fibroblast growth factor on cultured fetal rat calvaria. Metabolism (1980) 0.86
1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. Endocrinology (1989) 0.83
Partial purification and characterization of masking protein for beta-type transforming growth factor from rat platelets. Biochem Biophys Res Commun (1986) 0.82
Basic fibroblast growth factor as a wound healing hormone. Trends Pharmacol Sci (1988) 0.81
Endothelial cells in culture synthesize a potent bone cell active mitogen. Endocrinology (1986) 0.80
beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell (2001) 8.41
Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol (2000) 4.36
Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol (2002) 3.35
Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res (1978) 2.86
Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med (1999) 2.66
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging (2003) 2.19
Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol (1992) 2.09
A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. Arch Ophthalmol (1995) 2.09
Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med (1981) 1.56
A prospective randomized study of 4.1 French catheters utilizing the percutaneous right brachial approach for the diagnosis of coronary artery disease. Cathet Cardiovasc Diagn (1992) 1.53
An operant discrimination task allowing variability of reinforced response patterning. J Exp Anal Behav (1973) 1.33
Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor. J Biol Chem (1988) 1.32
The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group. Eur J Ophthalmol (1992) 1.28
Type beta transforming growth factor (TGF beta) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J Cell Physiol (1987) 1.22
Biophysical properties of mouse connexin30 gap junction channels studied in transfected human HeLa cells. J Physiol (1999) 1.20
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest (1996) 1.16
Immunochemical characterization of a band 3-like anion exchanger in collecting duct of human kidney. Am J Physiol (1987) 1.15
Influence of dynamic gap junction resistance on impulse propagation in ventricular myocardium: a computer simulation study. Biophys J (2001) 1.12
Penetration of timolol eye drops into human aqueous humour. Br J Ophthalmol (1981) 1.09
[The Leafhopper Neoaliturus haematoceps (Mulsant & Rey) is a vector of Spiroplasma citri in the Mediterranean]. Ann Inst Pasteur Microbiol (1987) 1.06
The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. Ophthalmology (1996) 1.03
Resolving voltage-dependent structural changes of a membrane photoreceptor by surface-enhanced IR difference spectroscopy. Proc Natl Acad Sci U S A (2008) 0.99
L-arginine-derived nitric oxide: a major determinant of uveal blood flow. Exp Eye Res (1993) 0.98
Plasmodium falciparum malaria acquired in Berlin, Germany. Lancet (1995) 0.98
Biologic and cytogenetic characteristics of leukemia in infants. Cancer (1989) 0.97
Influence of etiology on the course and outcome of acute pancreatitis. Pancreas (1996) 0.96
20 MHz ultrasonic imaging for quantitative assessment and documentation of early and late postradiation skin reactions in breast cancer patients. Radiother Oncol (1998) 0.96
NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene (1994) 0.96
Norfloxacin in acute urinary tract infections. Practitioner (1984) 0.96
Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. Scand J Clin Lab Invest Suppl (1999) 0.94
Development of a process for the biotechnological large-scale production of 4-hydroxyvalerate-containing polyesters and characterization of their physical and mechanical properties. Biomacromolecules (2001) 0.93
Biophysical properties of heterotypic gap junctions newly formed between two types of insect cells. J Physiol (1997) 0.93
Evaluation of eight fluorochrome combinations for simultaneous DNA-protein flow analyses. Stain Technol (1978) 0.93
Use of tunable nanopore blockade rates to investigate colloidal dispersions. J Phys Condens Matter (2010) 0.92
A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group. Am J Ophthalmol (1996) 0.91
Prompt return to normal of depressed right ventricular ejection fraction in acute inferior infarction. Br Heart J (1977) 0.90
Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol. J Steroid Biochem Mol Biol (2004) 0.90
Polyphasic identification of wild yeast strains isolated from Greek sourdoughs. Syst Appl Microbiol (2000) 0.89
Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial. J Antimicrob Chemother (1984) 0.89
[After care behavior of first-admission psychiatric patients during the year after their discharge]. Psychiatr Prax (1983) 0.88
Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells. Endocrinology (1999) 0.88
Bacterial expression of G-protein-coupled receptors: prediction of expression levels from sequence. Receptors Channels (2000) 0.87
Periodontal and caries experience in children with insulin-dependent diabetes mellitus. J Am Dent Assoc (1986) 0.87
Visualization of Surfactants on Nanostructured Palladium Clusters by a Combination of STM and High-Resolution TEM. Science (1995) 0.87
Transcription control and neuronal differentiation by agents that activate the LXR nuclear receptor family. Mol Cell Endocrinol (1999) 0.86
Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors. J Steroid Biochem Mol Biol (1998) 0.86
Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: a case report and analysis of the literature. Pediatr Hematol Oncol (1990) 0.86
Refolding of G-protein-coupled receptors from inclusion bodies produced in Escherichia coli. Biochem Soc Trans (1999) 0.85
The core gene of hepatitis B virus; subtype adw2. Nucleic Acids Res (1988) 0.85
Short- and long-term effects of digitalis on resting and posthandgrip hemodynamics in patients with coronary artery disease. Am J Cardiol (1977) 0.85
Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg (1983) 0.85
The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group. Eye (Lond) (1992) 0.83
Human protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates. J Bone Miner Res (1996) 0.83
Thymic hormone (THF) therapy in immunosuppressed children with lymphoproliferative neoplasia and generalized varicella. Biomedicine (1977) 0.83
The visual field in chronic simple glaucoma and ocular hypertension; its character, progress, relationship to the level of intraocular pressure and response to treatment. Eye (Lond) (1989) 0.83
Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections. J Antimicrob Chemother (1984) 0.83
Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis. Cancer (1987) 0.83
Platelet survival time and thromboembolism in patients with mitral valve prolapse. Circulation (1979) 0.83
Surface toxicity of timolol. Ophthalmology (1993) 0.83
Value of visual versus central quantitative measurements of angiographic success after percutaneous transluminal coronary angioplasty. NHLBI PTCA Registry Investigators. Am J Cardiol (1996) 0.83
The effect of THF in lymphoproliferative and myeloproliferative diseases in children. Ann N Y Acad Sci (1979) 0.82
254. The solution conformation of cyclo-glycyl-L-prolyl-glycyl-glycyl-L-prolyl-glycyl. Communication 22 (preliminary) on homodetic cyclic polypeptides. Helv Chim Acta (1972) 0.82
Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOB). Cancer (1986) 0.82
Slow-release artificial tear inserts in the treatment of dry eyes resulting from the oculomucocutaneous syndrome. Br J Ophthalmol (1983) 0.82
[Occupational reintegration of psychiatric patients hospitalized for the first time in the year following their discharge--results of a prospective longitudinal study]. Rehabilitation (Stuttg) (1986) 0.82
Changes in inflammatory mediators in experimental periodontitis in the rhesus monkey. Infect Immun (1993) 0.82
[Course of ambulatory after care of psychiatric patients admitted for the first time. Results of a 1-year and 5-year follow-up]. Nervenarzt (1988) 0.81
A double-masked, placebo-controlled evaluation of timolol in a gel vehicle. J Glaucoma (1993) 0.81
Effect of viscosity and iodine concentration of nonionic radiographic contrast media on coronary arteriography in patients. Am Heart J (1992) 0.81
[Selenium poisoning in fattening swine]. Tierarztl Prax (1992) 0.81
Thallium-201 myocardial imaging during maximal and submaximal exercise: comparison of submaximal exercise with propranolol. Am Heart J (1983) 0.81
High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. J Biol Chem (1990) 0.81
Abnormal chromosome behavior in human oocytes which remained unfertilized during human in vitro fertilization. J In Vitro Fert Embryo Transf (1985) 0.80
Application of digital techniques to selective coronary arteriography: use of myocardial contrast appearance time to measure coronary flow reserve. Am Heart J (1984) 0.80
[Current aspects of kinin research. I. Potentiation and blocking of biological kinin activity]. Z Klin Chem Klin Biochem (1970) 0.80
Arrangement of the disulphide bridges in human low-Mr kininogen. Biochem J (1987) 0.80
Penetration of timolol eye drops into human aqueous humour: the first hour. Br J Ophthalmol (1985) 0.80
[Occupational handicaps as risk factors for the readmission of psychiatric patients hospitalized for the first time--results of a prospective longitudinal study]. Rehabilitation (Stuttg) (1986) 0.80
In wounded sugar beet (Beta vulgaris L.) tap-root, hexose accumulation correlates with the induction of a vacuolar invertase isoform. J Exp Bot (2001) 0.80
Hormone-receptor interactions. Adrenocorticotropic hormone binding site increase in isolated fat cells by phenoxazones. Biochemistry (1974) 0.80
The effect of ketoprofen creams on periodontal disease in rhesus monkeys. J Periodontal Res (1996) 0.80
American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol (1999) 0.79
Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reprod Toxicol (1991) 0.79
The hemispheric distribution of Torpedo nicotinic receptors expressed in Xenopus oocytes. J Basic Clin Physiol Pharmacol (1996) 0.79
Effect of parent coronary arterial occlusion on left ventricular function after aortocoronary bypass surgery. Am J Cardiol (1977) 0.79
Mortality and rate of suicide of first admission psychiatric patients. A 5-year follow-up of a prospective longitudinal study. Psychopathology (1989) 0.79
The kinetics of gap junction currents are sensitive to the ionic composition of the pipette solution. Pflugers Arch (2000) 0.78
Abnormal platelet survival time in men with myocardial infarction and normal coronary arteriogram. Am J Cardiol (1978) 0.78
Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma: a pilot study. Int J Radiat Oncol Biol Phys (1981) 0.78
Effect of exercise on left ventricular ejection fraction in men with coronary artery disease. Am Heart J (1979) 0.78
Penetration of intravenously administered cefoxitin into the aqueous humor of inflamed human eyes. Am J Ophthalmol (1982) 0.78
Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitors. Pharmacogenetics (1995) 0.77
Juvenile and adult types of chronic granulocytic leukemia of childhood: growth patterns and characteristics of granulocyte-macrophage colony forming cells. Am J Hematol (1981) 0.77
Changes of interstitial fluid volume in superficial tissues detected by a miniature ultrasound device. J Appl Physiol (1985) (2000) 0.77
Comparative investigations on the activity of thiosulphate-sulphur transferase. Naturwissenschaften (1969) 0.77
A Delphi study of pediatric oncology nurses' facilitative behaviors. J Pediatr Oncol Nurs (1993) 0.77
Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time. Circulation (1979) 0.77
Factors involved in the increase of K+ efflux of erythrocytes in low chloride media. Biomed Biochim Acta (1987) 0.77
Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group. Am J Ophthalmol (1992) 0.77
Embryologic and cytogenetic effects of ethanol on preimplantation mouse embryos in vitro. Reprod Toxicol (1991) 0.77